Cyclodextrin-Based Delivery of the Annexin A1 Mimetic Peptide Ac2-26 Enhances Anti-Inflammatory Effects and Prevents Dengue-Induced Lethality in Combination with Antiviral Therapy

作者
Jenniffer Ramos Martins,Viviane Lima Batista,Lara Arribas Ramos,Celso Martins Queiroz‐Junior,Talita Fonseca,Angélica Samer Lallo Dias,LUISA CONY AYRES DE MIRANDA PEREIRA SALUSTIANO DA SILVA,Felipe Rocha da Silva Santos,Antônio C. Santos,Ivana S. Lula,Felipe Emanuel Oliveira Rocha,João L. Pereira,Edvaldo S. Lara,Thiago Moreno L. Souza,Lirlândia P. Sousa,Mauro Martins Teixeira,Pedro Pires Goulart Guimarães,Vivian Vasconcelos Costa
出处
期刊: [Cold Spring Harbor Laboratory]
标识
DOI:10.1101/2025.09.02.673789
摘要

ABSTRACT Severe dengue is characterized by systemic inflammation, cytokine storm, vascular leakage, and hemorrhagic manifestations, largely driven by the host immune response to dengue virus (DENV) infection. Despite its burden, no licensed antivirals or host-directed therapies are currently available. Our group has previously identified Annexin A1 (AnxA1) as an endogenous regulator of inflammation in dengue. Treatment with the AnxA1 peptidomimetic, Ac 2-26 , improved clinical outcomes in murine models of severe dengue by promoting resolution of inflammation without affecting viral control. To explore new delivery strategies, we developed a novel formulation of Ac 2-26 complexed with hydroxypropyl-β-cyclodextrin (CDX-Ac 2-26 ). In DENV-2-infected A129 mice, both intraperitoneal and oral CDX-Ac 2-26 improved clinical scores and reversed thrombocytopenia. Notably, CDX-Ac 2-26 reduced mast cell degranulation, MCPT-1 plasma levels, and CCL2 expression in spleen, with no effect on viral titers, indicating a host-targeted mechanism and overcoming the anti-inflammatory effects of the free peptide. Intraperitoneal administration achieved the same efficacy as oral dosing with only one-third of the dose. Importantly, the combination of CDX-Ac 2-26 with the antiviral nucleotide analog sofosbuvir fully prevented disease and mortality in infected mice, highlighting a combinatorial effect between host-directed and antiviral therapies. These findings underscore the therapeutic potential of anti-inflammatory/pro-resolving strategies in severe dengue and support the development of CDX-Ac 2-26 as a novel adjunctive treatment. Combining anti-inflammatory and antiviral approaches may enhance efficacy and reduce treatment-associated toxicity, offering a promising path for clinical translation. What is already known on this topic? Plasma levels of Annexin A1 are inversely correlated with the severity of clinical outcomes in dengue virus infection. The Annexin A1 peptidomimetic Ac 2-26 exhibits anti-inflammatory and pro-resolving effects against severe dengue in a murine model. What does this study add? The Ac 2-26 -cyclodextrin complex enhances the anti-inflammatory effects of the peptide against dengue virus infection, allowing for lower dosing and oral administration. The administration of the CDX-Ac 2-26 with a nucleoside analog antiviral exhibits a combinatorial effectt, providing complete protection against the lethal outcome of severe dengue. What is the clinical significance? Current dengue treatment relies on symptomatic management, as no directed anti-inflammatory agents or antivirals are currently available. We have identified a novel host-targeted strategy to resolve the disease. Our findings strongly support CDX-Ac 2-26 as a promising adjunctive treatment strategy in combination with antiviral therapy for severe dengue, highlighting the potential of combinatorial approaches.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
laglms发布了新的文献求助10
刚刚
dsjy发布了新的文献求助10
刚刚
cc完成签到,获得积分10
1秒前
英姑的应助被Songzhu采纳,获得10
1秒前
My_magnum_opus的应助被zhikaiyici采纳,获得30
1秒前
852的应助被XS_QI采纳,获得10
2秒前
晨曦发布了新的文献求助10
3秒前
123完成签到 ,获得积分10
4秒前
CodeCraft的应助被孟滴滴采纳,获得10
5秒前
NexusExplorer的应助被hyc采纳,获得10
6秒前
CodeCraft的应助被东京蔡徐坤采纳,获得10
6秒前
TR完成签到,获得积分10
6秒前
8秒前
科研通AI6.3的应助被刘甜甜采纳,获得30
8秒前
李爱国的应助被12345678采纳,获得10
8秒前
科研通AI6.3的应助被XZM采纳,获得10
9秒前
CipherSage的应助被renn采纳,获得10
9秒前
10秒前
orixero的应助被坦率的凉面采纳,获得10
10秒前
11秒前
心灵美雁易完成签到,获得积分10
11秒前
13秒前
JamesPei的应助被眼睛大大有采纳,获得10
13秒前
搜集达人的应助被Cynthia采纳,获得10
13秒前
不吃香菜发布了新的文献求助10
14秒前
东京蔡徐坤完成签到,获得积分20
15秒前
oumeili发布了新的文献求助10
15秒前
zzz发布了新的文献求助10
16秒前
okkk发布了新的文献求助10
16秒前
李宗洋完成签到,获得积分10
16秒前
17秒前
17秒前
18秒前
liuyimu完成签到,获得积分10
19秒前
19秒前
20秒前
21秒前
小嘉完成签到,获得积分10
21秒前
平常的丹秋发布了新的文献求助200
21秒前
master发布了新的文献求助30
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184061
求助须知:如何正确求助?哪些是违规求助? 9573151
关于积分的说明 21829878
捐赠科研通 7781058
什么是DOI,文献DOI怎么找? 3434216
关于科研通互助平台的介绍 2558337
邀请新用户注册赠送积分活动 2480674